RAVENNI, NICCOLO'
RAVENNI, NICCOLO'
A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate
2014-01-01 Galeazzi, M.; Bazzichi, L.; Sebastiani, G. D.; Neri, D.; Garcia, E.; Ravenni, N.; Giovannoni, L.; Wilton, J.; Bardelli, M.; Baldi, C.; Selvi, E.; Iluliano, A.; Minisola, G.; Caporali, R.; Prisco, E.; Bombardieri, S.
Branched Neurotensin peptides for tumor personalized therapy
2009-01-01 Brunetti, Jlenia; Falciani, Chiara; Lelli, Barbara; Pileri, Silvia; Cappelli, Alessandra; Pini, Alessandro; Ravenni, Niccolo'; Bencini, L; Moretti, Raffaele; Scatizzi, M; Menichetti, Caterina; Bracci, Luisa
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1
2012-01-01 Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Lozzi, Luisa; Depau, Lorenzo; Pini, Alessandro; Bracci, Luisa
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1
2012-01-01 Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Lozzi, Luisa; Depau, Lorenzo; Pini, Alessandro; Bracci, Luisa
Branched peptides as targeting agents for tumor imaging and therapy
2010-01-01 Brunetti, Jlenia; Falciani, Chiara; Lelli, Barbara; Ravenni, Niccolo'; Pini, Alessandro; Depau, Lorenzo; Lozzi, Luisa; Lapo, B.; Moretti, Raffaele; Bracci, Luisa
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors.
2013-01-01 Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Lozzi, Luisa; Depau, Lorenzo; Scali, Silvia; Bernini, Andrea; Pini, Alessandro; Bracci, Luisa
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer
2015-01-01 Brunetti, Jlenia; Falciani, Chiara; Lelli, Barbara; Minervini, Andrea; Ravenni, Niccolo'; Depau, Lorenzo; Siena, Giampaolo; Tenori, Eleonora; Menichetti, Stefano; Pini, Alessandro; Carini, Marco; Bracci, Luisa
Tumor selective targeting by branched peptides
2008-01-01 Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Pileri, Silvia; Pini, Alessandro; Lozzi, Luisa; Piccinelli, Ec; Menichetti, S; Pagliuca, C; Ravenni, Niccolo'; Moretti, R; Bencini, L; Cappelli, Alessandra; Bracci, Luisa
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents
2011-01-01 Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Depau, Lorenzo; Pini, Alessandro; Morelli, G; Tesauro, D; Accardo, A; Bracci, Luisa
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate | 1-gen-2014 | Galeazzi, M.; Bazzichi, L.; Sebastiani, G. D.; Neri, D.; Garcia, E.; Ravenni, N.; Giovannoni, L.; Wilton, J.; Bardelli, M.; Baldi, C.; Selvi, E.; Iluliano, A.; Minisola, G.; Caporali, R.; Prisco, E.; Bombardieri, S. | - | |
Branched Neurotensin peptides for tumor personalized therapy | 1-gen-2009 | Brunetti, Jlenia; Falciani, Chiara; Lelli, Barbara; Pileri, Silvia; Cappelli, Alessandra; Pini, Alessandro; Ravenni, Niccolo'; Bencini, L; Moretti, Raffaele; Scatizzi, M; Menichetti, Caterina; Bracci, Luisa | - | |
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 | 1-gen-2012 | Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Lozzi, Luisa; Depau, Lorenzo; Pini, Alessandro; Bracci, Luisa | - | |
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 | 1-gen-2012 | Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Lozzi, Luisa; Depau, Lorenzo; Pini, Alessandro; Bracci, Luisa | - | |
Branched peptides as targeting agents for tumor imaging and therapy | 1-gen-2010 | Brunetti, Jlenia; Falciani, Chiara; Lelli, Barbara; Ravenni, Niccolo'; Pini, Alessandro; Depau, Lorenzo; Lozzi, Luisa; Lapo, B.; Moretti, Raffaele; Bracci, Luisa | - | |
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. | 1-gen-2013 | Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Lozzi, Luisa; Depau, Lorenzo; Scali, Silvia; Bernini, Andrea; Pini, Alessandro; Bracci, Luisa | - | |
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer | 1-gen-2015 | Brunetti, Jlenia; Falciani, Chiara; Lelli, Barbara; Minervini, Andrea; Ravenni, Niccolo'; Depau, Lorenzo; Siena, Giampaolo; Tenori, Eleonora; Menichetti, Stefano; Pini, Alessandro; Carini, Marco; Bracci, Luisa | - | |
Tumor selective targeting by branched peptides | 1-gen-2008 | Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Pileri, Silvia; Pini, Alessandro; Lozzi, Luisa; Piccinelli, Ec; Menichetti, S; Pagliuca, C; Ravenni, Niccolo'; Moretti, R; Bencini, L; Cappelli, Alessandra; Bracci, Luisa | - | |
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents | 1-gen-2011 | Falciani, Chiara; Brunetti, Jlenia; Lelli, Barbara; Ravenni, Niccolo'; Depau, Lorenzo; Pini, Alessandro; Morelli, G; Tesauro, D; Accardo, A; Bracci, Luisa | - |